Wei Wang

Institute of Life Science, Jiyang College of Zhejiang A&F University, Zhuji, 311800, China
Author    Correspondence author
International Journal of Molecular Medical Science, 2024, Vol. 14, No. 1   doi: 10.5376/ijmms.2024.14.0010
Received: 04 Mar., 2024    Accepted: 05 Apr., 2024    Published: 15 Apr., 2024

This is an open access article published under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Wang W., 2024, The role of genomics in the prevention of cardiovascular diseases, International Journal of Molecular Medical Science, 14(1): 69-79 (doi: 10.5376/ijmms.2024.14.0010)

With the rapid development of high-throughput sequencing technology and the continuous progress of data analysis methods, genomics provides new perspectives and tools for the prevention of cardiovascular diseases. This study elaborates on the important role and potential impact of genomics in the prevention of cardiovascular diseases. Research has found that genomics not only helps guide drug selection and dosage adjustment, but also provides guidance for lifestyle interventions, thereby helping individuals reduce the risk of cardiovascular disease. By conducting in-depth research on the association between genes and cardiovascular disease, it is possible to accurately identify high-risk individuals and develop targeted prevention strategies. However, the application of genomics also faces ethical, privacy, technological, and legal challenges. In the future, with the continuous innovation of technology and the reduction of costs, genomics is expected to play a greater role in the prevention of cardiovascular diseases and make important contributions to human health.

Genomics; Cardiovascular disease; Prevention; Risk assessment; Personalized drug selection